Dose finding—a challenge in statistics.
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
A good understanding and characterization of the dose response relationship of any new compound is an important and ubiquitous problem in many areas of scientific investigation. This is especially true in the context of pharmaceutical drug development, where it is mandatory to launch safe drugs which demonstrate a clinically relevant effect. Selecting a dose too high may result in unacceptable safety problems, while selecting a dose too low may lead to ineffective drugs. Dose finding studies thus play a key role in any drug development program and are often the gate‐keeper for large confirmatory studies. In this overview paper we focus on definitive and confirmatory dose finding studies in Phase II or III, reviewing relevant statistical design and analysis methods. In particular, we describe multiple comparison procedures, modeling approaches, and hybrid methods combining the advantages of both. An outlook to adaptive dose finding methods is also given. We use a real data example to illustrate the methods, together with a brief overview of relevant software. (© 2008 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Simultaneous Inference in General Parametric Models
Hothorn, T., Bretz, F., & Westfall, P. (2008) · Biometrical Journal · doi:10.1002/bimj.200810425 · Cited by 13,847 · cited 1×
“Alternatively, simultaneous confidence lower or upper bounds for Dunnett’s 1-sided method can be computed with the multcomp package implemented in R (Bretz et al., 2008; Hothorn et al., 2008).”
MethodSelf-citationMixed-Effects Models in Sand S-PLUS
Pinheiro, J. C., & Bates, D. M. (2000) · Statistics and Computing · doi:10.1007/978-1-4419-0318-1 · Cited by 11,187
Self-citationA Multiple Comparison Procedure for Comparing Several Treatments with a Control
Dunnett, C. W. (1955) · Journal of the American Statistical Association · doi:10.1080/01621459.1955.10501294 · Cited by 6,094
Nonlinear Regression Analysis and Its Applications
Bates, D. M., & Watts, D. G. (1988) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316757 · Cited by 3,979
Multiple Comparison Procedures
Hochberg, Y., & Tamhane, A. C. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316672 · Cited by 2,389
Seber, G. A. F., & Wild, C. J. (1989) · Wiley Series in Probability and Statistics · doi:10.1002/0471725315 · Cited by 1,962
Assessment and Propagation of Model Uncertainty
Draper, D. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02015.x · Cited by 1,599 · cited 1×
“Ignoring model uncertainty thus can lead to highly undesirable effects, see Chatfield (1995), Draper (1995), and Hjorth (1994).”
BackgroundOrder Restricted Statistical Inference.
Santner, T., Robertson, T., Wright, F. T., & Dykstra, R. L. (1990) · Journal of the American Statistical Association · doi:10.2307/2289813 · Cited by 1,586
On closed testing procedures with special reference to ordered analysis of variance
MARCUS, R., ERIC, P., & GABRIEL, K. R. (1976) · Biometrika · doi:10.1093/biomet/63.3.655 · Cited by 1,423 · cited 1×
“This method is based on the closure principle (Marcus et al., 1976) for controlling the overall type I error rate.”
MethodGroup Sequential Methods with Applications to Clinical Trials
Jennison, C., & Turnbull, B. W. (1999) · Chapman & Hall/CRC eBooks · doi:10.1201/9780367805326 · Cited by 1,336
Research works printed but not linked: 3
- Bornkamp B.(2006).Comparison of model‐based and model‐free approaches for the analysis of dose response studies. Diploma thesis University of Dortmund.
- 1991, FDC Reports from May 6, 1991, The Pink Sheet, 53, 14
- 10.1080/10543400701645140 · doi:10.1080/10543400701645140
Cited by
Workgroup, E. M., Marshall, S., Burghaus, R., Cosson, V, Cheung, S., Chenel, M., DellaPasqua, O., Frey, N., Hamrén, B., Harnisch, L., et al. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12049 · Cited by 373
Dose-response meta-analysis of differences in means
Crippa, A., & Orsini, N. (2016) · BMC Medical Research Methodology · doi:10.1186/s12874-016-0189-0 · Cited by 202
“The most common choice in dose findings [2] is the use of the Emax model which is expressed in terms of three”
BackgroundMethodAerobic Exercise and Weight Loss in Adults: A Systematic Review and Dose-Response Meta-Analysis
Jayedi, A., Soltani, S., Emadi, A., Zargar, M.-S., & Najafi, A. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.52185 · Cited by 172
Adjedj, J., Tóth, G. G., Johnson, N. P., Pellicano, M., Ferrara, A., Floré, V., Gioia, G. D., Barbato, E., Müller, O., & Bruyne, B. D. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.04.028 · Cited by 125
“Dose-response analysis was performed in 2 ways (14).”
Jayedi, A., Zeraattalab-Motlagh, S., Jabbarzadeh, B., Hosseini, Y., Jibril, A. T., Shahinfar, H., Mirrafiei, A., Hosseini, F., & Shab-Bidar, S. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac066 · Cited by 85
Metadata
- Authors
- Bretz, F., Hsu, J., Pinheiro, J., & Liu, Y.
- Affiliations
- Novartis (Switzerland) (CH)
- The Ohio State University (US)
- Corresponding author
- Bretz, Frank
- Venue
- Biometrical Journal
- Publisher
- Wiley
- Published
- 2008-07-29
- Volume
- 50
- Issue
- 4
- Pages
- 480-504
- ISSN
- 0323-3847 (ISSN-L)
- 1521-4036
- OpenAlex
- W1994654755
- Cited by
- 101
- References
- 68
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 7 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 9 · 2014: 9 · 2013: 6 · 2012: 6
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biometrical Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Management Science and Operations Research › Optimal Experimental Design Methods
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- dose-finding, dose-response relationship, drug development, multiple comparisons, dose-response modeling, statistical design, phase II and III clinical trials
- MeSH terms
- Algorithms, Clinical Trials as Topic, Dose-Response Relationship, Drug, Pharmaceutical Preparations, Humans, Software, Models, Statistical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.